Clinical trials
Recruiting Phase 4 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 2 |
| Novartis Pharmaceuticals | 2 |
| Saint Petersburg State University, Russia | 2 |
| Valenta Pharm JSC | 2 |
| Amur State Medical Academy | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology | 1 |
| Guerbet | 1 |
| Penza State University | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 2 |
| Adjustment Disorders | 1 |
| Agnosia | 1 |
| Anxiety Disorders | 1 |
| Autoimmune Diseases | 1 |
| Blast Crisis | 1 |
| Breast Neoplasms | 1 |
| Burkitt Lymphoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cerebral Infarction | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.